Welcome to LookChem.com Sign In|Join Free
  • or
7-IsoquinolinaMine, 1-chloro-3-(3-Methoxyphenyl)-N,N-diMethyl-, also known as Ketotifen, is a pharmaceutical drug with a molecular formula of C17H17ClN2O. It is a chemical compound that exhibits antihistamine and anti-asthmatic properties, making it a valuable treatment for various allergic conditions and respiratory disorders.

1029009-59-3

Post Buying Request

1029009-59-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1029009-59-3 Usage

Uses

Used in Pharmaceutical Industry:
7-IsoquinolinaMine, 1-chloro-3-(3-Methoxyphenyl)-N,N-diMethylis used as an antihistamine and anti-asthmatic agent for the treatment of allergic reactions and asthma. It works by inhibiting the release of allergic mediators such as histamine and leukotrienes from cells involved in allergic reactions, thus reducing the symptoms of allergies and asthma.
Used in Allergy Treatment:
7-IsoquinolinaMine, 1-chloro-3-(3-Methoxyphenyl)-N,N-diMethylis used as a therapeutic agent for the management of allergic conditions, including allergic rhinitis, urticaria, and atopic dermatitis. Its antihistamine properties help alleviate symptoms such as itching, redness, and swelling associated with these conditions.
Used in Asthma Management:
7-IsoquinolinaMine, 1-chloro-3-(3-Methoxyphenyl)-N,N-diMethylis used as a bronchodilator and anti-inflammatory agent in the treatment of asthma. It helps to relax the airways and reduce inflammation, providing relief from shortness of breath, wheezing, and coughing.
Used in Ophthalmic Solutions:
7-IsoquinolinaMine, 1-chloro-3-(3-Methoxyphenyl)-N,N-diMethylis used as an active ingredient in ophthalmic solutions for the treatment of allergic conjunctivitis. It helps to alleviate eye redness, itching, and tearing associated with this condition.
While 7-IsoquinolinaMine, 1-chloro-3-(3-Methoxyphenyl)-N,N-diMethylis generally well-tolerated, some potential side effects include drowsiness, dizziness, and dry mouth. It is typically administered orally in the form of tablets or oral solution, and is also available as an ophthalmic solution for the treatment of allergic conjunctivitis.

Check Digit Verification of cas no

The CAS Registry Mumber 1029009-59-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,2,9,0,0 and 9 respectively; the second part has 2 digits, 5 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1029009-59:
(9*1)+(8*0)+(7*2)+(6*9)+(5*0)+(4*0)+(3*9)+(2*5)+(1*9)=123
123 % 10 = 3
So 1029009-59-3 is a valid CAS Registry Number.

1029009-59-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name [1-Chloro-3-(3-methoxyphenyl)isoquinolin-7-yl]dimethylamine

1.2 Other means of identification

Product number -
Other names [1-Chloro-3-(3-methoxyphenyl)isoquinolin-7-yl]dimethylamine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1029009-59-3 SDS

1029009-59-3Relevant academic research and scientific papers

Synthesis, in vitro and in vivo evaluation of 3-arylisoquinolinamines as potent antitumor agents

Yang, Su Hui,Van, Hue Thi My,Le, Thanh Nguyen,Khadka, Daulat Bikram,Cho, Suk Hee,Lee, Kyung-Tae,Chung, Hwa-Jin,Lee, Sang Kook,Ahn, Chang-Ho,Lee, Young Bok,Cho, Won-Jea

scheme or table, p. 5277 - 5281 (2010/10/21)

In the search for potent water-soluble 3-arylisoquinolines, several 3-arylisoquinolinamines were designed and synthesized. Various substituted 3-arylisoquinolinamines exhibited strong cytotoxic activity against eight different human cancer cell lines. In

5, 6, or 7-Substituted - 3-(hetero) arylisoquinolinamine derivatives and therapeutic use thereof

-

, (2008/12/07)

The present invention relates to 5, 6, or 7-substituted-3-(hetero)arylisoquinolinamine derivatives represented by general formula D, their pharmacologically acceptable salts thereof, and compositions containing such compounds. Methods for treating hyperproliferative disorders by administering the compounds are also included.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1029009-59-3